logo

OPK

OPKO Health·NASDAQ
--
--(--)
--
--(--)
3.33 / 10
Netural

Fundamental analysis of OPKO Health shows a weak profile (score 3.3/10). Key headwinds include a year-over-year revenue decline of -13.42%, while the interest-coverage ratio of 15.48 offers some financial flexibility. Metrics like Days Sales Outstanding (62.6) and Cash-MV (-0.067) fall in less favorable quartiles, indicating collection inefficiencies and modest cash-flow concerns. Overall, the company's operational momentum is tepid, supporting a cautious fundamental view.

Fundamental(3.33)SentimentTechnical

Analysis Checks(7/10)

Revenue-MV
Value0.04
Score2/3
Weight16.63%
1M Return7.73%
Total operating revenue (YoY growth rate %)
Value-13.42
Score1/3
Weight-1.24%
1M Return-0.79%
Days sales outstanding
Value62.61
Score2/3
Weight1.85%
1M Return1.10%
Profit-MV
Value0.46
Score2/3
Weight16.95%
1M Return8.45%
Net income-Revenue
Value-0.05
Score2/3
Weight16.96%
1M Return8.45%
PB-ROE
Value-0.53
Score3/3
Weight22.98%
1M Return12.83%
Interest coverage ratio (EBIT / Interest expense) (%)
Value15.48
Score2/3
Weight-1.70%
1M Return-1.11%
Operating revenue (YoY growth rate %)
Value-13.42
Score1/3
Weight-1.20%
1M Return-0.76%
Asset-MV
Value-0.50
Score0/3
Weight12.10%
1M Return5.75%
Cash-MV
Value-0.07
Score2/3
Weight16.66%
1M Return8.41%
Is OPK fundamentally strong?
  • OPK scores 3.33/10 on fundamentals and holds a Fair valuation at present. Backed by its -14.56% ROE, -28.10% net margin, -5.28 P/E ratio, 0.73 P/B ratio, and -26.32% earnings growth, these metrics solidify its Netural investment rating.